Skip to main content
Fig. 4 | Antimicrobial Resistance & Infection Control

Fig. 4

From: Shifting trends and age distribution of ESKAPEEc resistance in bloodstream infection, Southwest China, 2012–2017

Fig. 4

Antimicrobial resistance profiles of ESKAPEEc pathogens in adult and pediatric BSIs. a ECO, Escherichia coli; b KPN, Klebsiella pneumoniae; c ECL, Enterobacter cloacae; d ABA, Acinetobacter baumannii; e PAE, Pseudomonas aeruginosa; f SAU, Staphylococcus aureus; g EFM, Enterococcus faecium. PEN: Penicillin G; AMP: Ampicillin; OXA: Oxacillin; PIP: Piperacillin; TZP: Piperacillin/Tazobactam; CZO: Cefazolin; CXM: cefuroxime; CAZ: Ceftazidime; CRO: Ceftriaxone; FEP: Cefepime; ATM: Aztreonam; ETP: Ertapenem; IMP: Imipenem; MEM: Meropenem; CIP: Ciprofloxacin; LEV: Levofloxacin; MXF: Moxifloxacin; AMK: Amikacin; GEN: Gentamicin; TOB: Tobramycin; ERY: Erythromycin; CLI: clindamycin; CHL: chloramphenicol; TCY: Tetracycline; LZD: Linezolid; VAN: Vancomycin. Asterisks indicate statistical significance as P values were less than 0.05

Back to article page